Acid Suppression Does Not Improve Laryngomalacia Outcomes but Treatment for Oropharyngeal Dysphagia Might Be Protective - 23/10/21
Abstract |
Objective |
To determine whether the use of acid suppression and thickened feeds impact laryngomalacia outcomes in infants, including supraglottoplasty risk, time to supraglottoplasty, and hospitalization risk.
Study design |
We performed a retrospective cohort study to compare risk and time with supraglottoplasty and frequency and duration of hospitalizations for infants diagnosed with laryngomalacia at Boston Children's Hospital between January 1 and December 31, 2017. The primary outcomes were supraglottoplasty requirement, time to supraglottoplasty, and hospitalization risk. Multivariate analyses were performed to determine predictors of supraglottoplasty and hospitalization risk after adjusting for laryngomalacia severity and comorbidities in addition to propensity score adjustment. Kaplan–Meier curves were created to determine the impact of acid suppression use on time to supraglottoplasty.
Results |
In total, 236 subjects with mean age 62.6 ± 4 days were included in the analysis; 55% were treated with acid suppression. Subjects treated with acid suppression had a greater risk of supraglottoplasty (hazard ratio 3.36, 95% CI 1.36-8.29, P = .009), shorter time to supraglottoplasty (5.64 ± 0.92 vs 7.98 ± 1.92 months, P = .006), and increased respiratory hospitalization risk (relative risk 1.97, 95% CI 1.01-3.85, 0.047), even after adjustment for covariates. Subjects receiving thickening had fewer respiratory hospitalization nights and longer time to supraglottoplasty (9.3 ± 1.7 vs 4.56 ± 0.73 months, P = .004), even after adjustment.
Conclusions |
Acid suppression use does not reduce the frequency of supraglottoplasty and related hospitalizations compared with untreated subjects. However, patients treated with thickening have decreased hospitalization and longer time to supraglottoplasty, suggesting that thickening of feeds may be a preferred intervention over acid suppression.
Le texte complet de cet article est disponible en PDF.Keywords : gastroesophageal reflux, aspiration, supraglottoplasty
Abbreviations : CFE, GER, H2RA, PPI, RR, VFSS
Plan
| Supported by The Translational Research Program Senior Investigator Award at Boston Children's Hospital (to R.R.), National Institutes of Health (NIH) R01 DK097112-01 (to R.R.), and NIH T32 DK007477-33 (to D.D.). The authors declare no conflicts of interest. |
|
| Portions of this study were presented at Digestive Diseases Week, May 18-21, 2019, San Diego, California; NASPGHAN, October 17-19, 2019, Chicago, Illinois; and the SENTAC/Aerodigestive Society Combined Meeting, December 4-5, 2020 (virtual). |
Vol 238
P. 42 - novembre 2021 Retour au numéro
Article précédent
- Cytokine Profile Elevations on Admission Can Determine Risks of Severe Acute Pancreatitis in Children
- Peter R. Farrell, Elaina K. Jones, Lindsey Hornung, Tyler Thompson, Jyoti Patel, Tom K. Lin, Jaimie D. Nathan, David S. Vitale, Aida Habtezion, Maisam Abu-El-Haija
- Sclerosing Cholangitis in Pediatric Inflammatory Bowel Disease: Early Diagnosis and Management Affect Clinical Outcome
- Kai O. Hensel, Eirini Kyrana, Nedim Hadzic, Jake Mann, Giorgina Mieli-Vergani, Marco Gasparetto, Robert Heuschkel, Gabriele Noble-Jamieson, Marianne Samyn
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?